Citation Impact

Citing Papers

Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial
2011
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
2005 StandoutScience
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer
2005 StandoutNobel
The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives
1999 StandoutNature
AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis
1996 Standout
Adrenalectomy for Familial Pheochromocytoma in the Laparoscopic Era
2002
Treatment of Medulloblastoma with Hedgehog Pathway Inhibitor GDC-0449
2009 Standout
Pheochromocytoma in multiple endocrine neoplasia type 2: European study
1995
Positional cloning moves from perditional to traditional
1995
Thyroid cancer
2016 Standout
Variable Expression of the V1 Vasopressin Receptor Modulates the Phenotypic Response of Steroid-Secreting Adrenocortical Tumors1
1998
Multivariate analysis of patients with medullary thyroid carcinoma: Prognostic significance and impact on treatment of clinical and pathologic variables
1996
Pheochromocytomas, Multiple Endocrine Neoplasia Type 2, and von Hippel-Lindau Disease
1993
Sh2 And Sh3 Domains In Signal Transduction
1994
Oncogenic kinase signalling
2001 StandoutNature
The pressure rises: update on the genetics of phaeochromocytoma
2002
Functional receptor for GDNF encoded by the c-ret proto-oncogene
1996 Nature
Notch Receptors, Partners and Regulators: From Conserved Domains to Powerful Functions
1998
Molecular basis of the VHL hereditary cancer syndrome
2002 StandoutNobel
Cushing's syndrome
2015 Standout
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
1994 Standout
Phaeochromocytoma
2005 Standout
Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold
2010
Defects in enteric innervation and kidney development in mice lacking GDNF
1996 StandoutNature
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)
2010
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo
2004 StandoutNobel
Medullary Thyroid Carcinoma
2007
The Hallmarks of Cancer
2000 Standout
Lessons from Hereditary Colorectal Cancer
1996 Standout
Colorectal cancer
2013 Standout
Phaeochromocytoma—recent progress in its management
2000
Medullary Thyroid Cancer: Analyses of Survival and Prognostic Factors and the Role of Radiation Therapy in Local Control
1996
Analysis of the efficacy and toxicity of sorafenib in thyroid cancer: a phase II study in a UK based population
2011
Disruption of oxygen homeostasis underlies congenital Chuvash polycythemia
2002 StandoutNobel
Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein
1999 StandoutNobel
von Hippel-Lindau disease
2003 Standout
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
β-Arrestin1 Interacts with the Catalytic Domain of the Tyrosine Kinase c-SRC
2000 StandoutNobel
Large-Scale Variation Among Human and Great Ape Genomes Determined by Array Comparative Genomic Hybridization
2003
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Chromosomal translocations in human cancer
1994 Nature
C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B
2000
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
2005 Standout
Treatment of medullary thyroid carcinoma: an update.
2001
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
1996
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret
1994 StandoutNature
Hereditary Colorectal Cancer
2003 Standout
The gene for the naevoid basal cell carcinoma syndrome acts as a tumour-suppressor gene in medulloblastoma
1997
GDNF signalling through the Ret receptor tyrosine kinase
1996 StandoutNature
Genetic predisposition to phaeochromocytoma: analysis of candidate genes GDNF, RET and VHL
1997
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
2003
Enhanced Phosphatidylinositol 3-Kinase Activity and High Phosphorylation State of Its Downstream Signalling Molecules Mediated by Ret with the MEN 2B Mutation
1999
Hox11 paralogous genes are essential for metanephric kidney induction
2002 StandoutNobel
Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease
1994 Nature
Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
1994 Standout
Mutations of the RET proto-oncogene in Hirschsprung's disease
1994 Nature
Environmental and Heritable Factors in the Causation of Cancer — Analyses of Cohorts of Twins from Sweden, Denmark, and Finland
2000 Standout
Multiple endocrine neoplasia type 2 andRET: from neoplasia to neurogenesis
2000
Sporadic Pheochromocytomas Are Rarely Associated with Germline Mutations in thevhlTumor Suppressor Gene or theretProtooncogene1
1997
Renal agenesis and the absence of enteric neurons in mice lacking GDNF
1996 StandoutNature
Ubiquitination of hypoxia-inducible factor requires direct binding to the β-domain of the von Hippel–Lindau protein
2000 StandoutNobel
Genetic and epigenetic control in neural crest development
1994
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 Standout
HIF activation identifies early lesions in VHL kidneys
2002 StandoutNobel
Genomic Sequence and Transcriptional Profile of the Boundary Between Pericentromeric Satellites and Genes on Human Chromosome Arm 10p
2003
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Routine Measurement of Serum Calcitonin is Useful for Early Detection of Medullary Thyroid Carcinoma in Patients with Nodular Thyroid Diseases
2001
Activation of RET as a Dominant Transforming Gene by Germline Mutations of MEN2A and MEN2B
1995 Science
Antioncogenes and human cancer.
1993
Medullary Thyroid Carcinoma
1998
Cancer Cell Cycles
1996 StandoutScience
Expression of the c-ret proto-oncogene during mouse embryogenesis
1993
All in the (cancer) family
1993
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
1996 StandoutScience
After chronic myelogenous leukemia: tyrosine kinase inhibitors in other hematologic malignancies
2004
Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal Tumors
1998 StandoutScience
W/kit gene required for interstitial cells of Cajal and for intestinal pacemaker activity
1995 StandoutNature
Advances in the Chemistry of Tetrahydroquinolines
2011 Standout
CHASING THE CANCER DEMON
2000
Familial Isolated Pituitary Adenomas (FIPA) and the Pituitary Adenoma Predisposition due to Mutations in the Aryl Hydrocarbon Receptor Interacting Protein (AIP) Gene
2013
Constitutive activation of c-kit in FMA3 murine mastocytoma cells caused by deletion of seven amino acids at the juxtamembrane domain
1996
Isolated familial pheochromocytoma as a variant of von Hippel-Lindau disease.
1996
Pheochromocytoma: State-of-the-Art and Future Prospects
2003
Fas Preassociation Required for Apoptosis Signaling and Dominant Inhibition by Pathogenic Mutations
2000 StandoutScienceNobel
Molecular genetic diagnosis of von Hippel-Lindau disease in familial phaeochromocytoma.
1995
Reactive oxygen species are critical for the growth and differentiation of medullary thyroid carcinoma cells.
2000
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
1997 Science
Notch Signaling: Cell Fate Control and Signal Integration in Development
1999 StandoutScience
Mutations in the RET proto-oncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic phaeochromocytomas.
1995
Guidelines for the management of thyroid cancer
2014 Standout
Structural Dynamics of Eukaryotic Chromosome Evolution
2003 StandoutScience
Consequences of Direct Genetic Testing for Germline Mutations in the Clinical Management of Families With Multiple Endocrine Neoplasia, Type II
1995
Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.
2000
Human Homolog of patched , a Candidate Gene for the Basal Cell Nevus Syndrome
1996 StandoutScience
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Role ofVHLGene Mutation in Human Cancer
2004 StandoutNobel
Mutations in the Extracellular Domain Cause RET Loss of Function by a Dominant Negative Mechanism
1998
The Human Genome Project: Reaching the Finish Line
1998 StandoutScienceNobel
Thyroid carcinoma
2003 Standout
Recent Advances in Genetics, Diagnosis, Localization, and Treatment of Pheochromocytoma
2001
Genetic Testing for Cancer Predisposition
2001
Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline
2014 Standout

Works of Julia K. Moore being referenced

Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2
1993
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
1993 Nature
A multiple interval physical map of the pericentromeric region of human chromosome 10
1994
Duplicated KOX zinc finger gene clusters flank the centromere of human chromosome 10: evidence for a pericentric inversion during primate evolution
1993
Rankless by CCL
2026